The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT)
Efficacy of the Erector Spinae Plane Block for Abdominal Pain From Gastrointestinal Malignancies
Abramson Cancer Center at Penn Medicine
25 participants
Dec 11, 2025
INTERVENTIONAL
Conditions
Summary
This study will target patients with gastrointestinal (GI) malignancy who present to any of 4 Penn Medicine emergency departments (EDs) with intractable abdominal pain. We will offer eligible patients an erector spinae plane block (ESPB), a regional anesthesia technique which is already offered to such patients in the ED at the University of Pennsylvania Healthy System (UPHS), for their intractable abdominal pain. We will compare the outcomes of this prospective cohort of patients to a matched historical control of patients with GI malignancy who were treated in the ED during the same time period as recruitment, but who were not recruited to partake in the study and who were managed with standard of care. Opioid consumption as measured by total milligram morphine equivalents (MMEs) over a 24-hour period and hospital length of stay (LOS) will be compared between cohorts. Additionally, for the ESPB cohort, pain level pre/post ESPB, and functionality and satisfaction with pain management at 24 hours will also be examined.
Eligibility
Inclusion Criteria2
- Patients age \> 18 years old with GI malignancy presenting to a Penn Medicine ED with intractable abdominal pain.
- Same-day or recent CT scan of the abdomen / pelvis which demonstrates that the patient's abdominal pain can be reasonably attributed to a malignant source.
Exclusion Criteria7
- Allergy to ropivacaine or history of local anesthetic systemic toxicity.
- Pregnancy
- Incarcerated
- Patients being admitted for serial abdominal examinations to determine their surgical course.
- Altered mental status or inability for patient to consent for the procedure
- Hemodynamic instability
- Previously enrolled in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The abdominal viscera, from the stomach to midway through the sigmoid colon, derives its sensory innervation from afferent fibers that travel with, but are distinct from, the sympathetic nerve fibers from the 5th thoracic (T5) to the 2nd lumbar (L2) spinal levels (Moore et al). These fibers converge at the celiac plexus, located near the celiac artery and the aorta. From there, they bifurcate into the paravertebral sympathetic chain and subsequently ascend to the spinal cord and integrate into the central nervous system (Lohse et al). The celiac plexus block is an invasive procedure performed by an interventional anesthesiologist or palliative care specialist to lyse the celiac plexus and has been shown to reduce pain and opiate use in patients suffering from GI malignancy (Ashlock et al). While there are multiple methods to perform a celiac plexus block, it involves a steep needle trajectory either posteriorly through the retroperitoneum or anteriorly through the abdominal wall close
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07211386